This is one that we see very rarely, but it sure is nice to have a nice summary for counselling in one place in those cases!
Click here and scroll down for previous newsletters.
1. Pictured Counselling Cue Card: a free sample of our counselling reference
2. Patient Consultation: exactly what a pharmacist may say to a patient picking up this medication, with formatting to show where the information is coming from on the cue card
Clearly, there are nuances that may not be captured in this format. The goal here is to provide you with an example of how a pharmacist may counsel a patient. Basic counselling tactics (e.g. showing the patient the labeled medication as you read it, having the patient repeat the information in their own words, double checking allergies, and so on) may not be depicted in the interest of keeping the content concise.

RPh: Hi! Is this medication new for you?
Patient: Yes.
RPh: Ok. What has (prescriber) told you?
Patient: They said it would help my Parkinson's.
RPh: Ok. This medication is called CABERGOLINE, also known as DOSTINEX, you'll take it (as directed). It's in the family of what's called dopamine agonists, but basically it helps by reducing symptoms like stiffness and trembling caused by Parkinson Disease, which can help with your activities of daily living. It's very important that you take this medication on time, and do not stop taking it or reduce your dose without speaking to your prescriber or pharmacist. You may notice confusion, erratic movements, hallucinations, dizziness, or swelling in the limbs; let us know right away if these become bothersome. Taking it with food can help with upset stomach. Tell us right away if you notice abrupt sleepiness or a decrease in impulse control. Some warnings that come with this medication include lung/heart issues and use with some antidepressants/antipsychotics. Keep it at room temperature.
RPh: Did you have any questions?
Patient: Is this medication for me, considering I am only 35 years old?
RPh: If you've already tried other options, this one might be better in younger Parkinson Disease patients such as yourself.
Patient: Thanks!
We hope you have found this useful, and please reply to this email with any feedback or topic suggestions you can; it will be the key to making this newsletter the best it can be.
Comments